Oct. 23, 2026

Hospital Detox Shakeup and NFL Star Sidelined

Key Takeaways

A recent phase three trial on nicotinamide riboside for early Parkinson's disease successfully boosted NAD metabolism over 52 weeks, but unfortunately showed no clinical benefit for patients.
When comparing phenobarbital vs diazepam for hospital alcohol withdrawal management, large-scale findings reveal similar length of hospital stays and ventilation rates between the two treatments.
Patients treated with phenobarbital for alcohol withdrawal exhibited fewer self-directed discharges compared to those on diazepam protocols.
Despite promising observational data on phenobarbital vs diazepam, traditional diazepam protocols likely remain standard practice pending further randomized controlled trials.
Healthcare professionals must also stay vigilant regarding rising national measles trends and recent FDA regulatory warning letters issued to major retailers like Amazon and Walmart.

Show Notes

Friday, October 23, 2026

In today's episode, Dr. Alok Patel (@alokpatelmd) & Adam Rose (@adjoro) cover a phase three trial of nicotinamide riboside in early Parkinson disease. Over 52 weeks, the supplement boosted NAD metabolism but showed no clinical benefit, raising questions for NAD boosting strategies. They also walk through a large hospital comparison of phenobarbital and diazepam for alcohol withdrawal, with similar stays and ventilation rates and fewer self directed discharges on phenobarbital, and why diazepam protocols may stay the course pending randomized trials. Plus: they also discuss national measles trends, FDA warning letters to Amazon and Walmart, and more.

Coverage Timeline:

(00:00) Intro (01:05) NR Supplement Trial for Parkinson's (03:01) NAD Supplements & Influencer Hype (04:49) Phenobarbital vs. Diazepam (07:30) Measles Surge in US (08:27) New Sunscreen Ingredient BEMT (09:01) Blood Clots

Have a story, think we missed something, want to say hi, or curious to learn about the Medlines team? Visit www.medlinespod.com or email medlines@human-content.com.

Sources & Media Attributions for Today's Episode Available At: www.medlinespod.com/sources

Medlines is a Human Content Production

Frequently Asked Questions

How do phenobarbital vs diazepam compare in hospital alcohol withdrawal management?

A large hospital comparison shows that phenobarbital and diazepam yield similar hospital stays and ventilation rates, though phenobarbital is associated with fewer self-directed discharges.

Did nicotinamide riboside show clinical benefits in early Parkinson's disease?

No, while a 52-week phase three trial found that the supplement effectively boosted NAD metabolism, it demonstrated no measurable clinical benefit for early Parkinson's patients.

What other healthcare headlines were covered in this episode of Medlines?

Hosts Dr. Alok Patel and Adam Rose also discussed national measles trends, FDA warning letters sent to Amazon and Walmart, and new sunscreen ingredients.